Chemed Corporation (NYSE:CHE) Q2 2022 Earnings Conference Call July 28, 2022 10:00 AM ET

Company Participants

Holley Schmidt - Assistant Controller

Kevin McNamara - President and Chief Executive Officer

Dave Williams - Executive Vice President and Chief Financial Officer

Nick Westfall - President and Chief Executive Officer of Chemed VITAS Healthcare Corporation Subsidiary

Conference Call Participants

Kevin Fischbeck - Bank of America

Ben Hendrix - RBC Capital Markets

Operator

Good day and welcome to the Chemed Corporation Second Quarter 2022 Earnings Conference Call. After the speakers' presentation, there will be a question-and-answer session. As a reminder, this call is being recorded.

I’d now like to turn the call over to Holley Schmidt, you may begin.

Holley Schmidt

Good morning. Our conference call this morning will review the financial results for the second quarter of 2022 ended June 30, 2022. Before we begin, let me remind you that the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call.

During the course of this call, the company will make various remarks concerning management's expectations, predictions, plans, and prospects that constitute forward-looking statements. Actual results may differ materially from those projected by these forward-looking statements as a result of a variety of factors including those identified in the company's news release of July 27 and in various other filings with the SEC. You are cautioned that any forward-looking statements reflect management's current view only and that the company undertakes no obligation to revise or update such statements in the future.

In addition, management may also discuss non-GAAP operating performance results during today's call, including earnings before interest, taxes, depreciation and amortization or EBITDA and adjusted EBITDA. A reconciliation of these non-GAAP results is provided in the company's press release dated July 27, which is available on the company's website at chemed.com.

I would now like to introduce our speakers for today, Kevin McNamara, President and Chief Executive Officer of Chemed Corporation; Dave Williams, Executive Vice President and Chief Financial Officer of Chemed; and Nick Westfall, President and Chief Executive Officer of Chemed VITAS Healthcare Corporation subsidiary.

I will now turn the call over to Kevin McNamara.

Kevin McNamara

Thank you, Holley. Good morning. Welcome to Chemed Corporation's second quarter 2022 conference call. I will begin with the highlights for the quarter and Dave and Nick will follow-up with additional operating detail. I will then open the call for questions.